SPP1 and Miyoshi myopathy: The aim of the present study was to explore circulating levels of sRANKL, periostin, and osteopontin in newly diagnosed MM (NDMM) patients at diagnosis and in the course of their treatment, including autologous stem cell transplantation (ASCT), and to assess possible correlations with laboratory data, disease stage, and MBD.